Skip to content

The mechanical and medical prevention of Lower Extremity Deep Venous Thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study

The mechanical and medical prevention of Lower Extremity Deep Venous Thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15007324
Enrollment
Unknown
Registered
2015-10-30
Start date
2015-11-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

deep venous thrombosis formation post gynecologic pelvic surgery

Interventions

GCS:graduated compression stockings
GCS+LMWH:graduated compression stockings +low molecular weight heparin
GCS+IPC:graduated compression stockings + intermittent pneumatic compression
GCS+LMWH+IPC:graduated compression stockings +low molecular weight heparin+intermittent pneumatic compression

Sponsors

Beijing Chaoyang Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: patients who are participating voluntarily; who are >=45 yr or who are less than 45 yr but with a diagnosis of gynecologic malignancy; who do not present LDVT and PE as evidenced by ultrasound; who are diagnosed with gynecologic malignancy or whose expected surgery time >1h; who are of positive DVT and/or PE history or are stratified as medium or high risk patients; operation modality: pelvic laparoscopy, laparotomy or vaginal.

Exclusion criteria

Exclusion criteria: patients who are thrombophletitis or pulmonary embolism; preoperative acute LDVT as evidenced by ultrasound; who are with thrombocytopenia(plt count<100*10^9) or coagulopathy; who are using anticoagulants, i.e. aspirine ect; who are prohemorrhagic as evidenced by past history of intracranial hemorrhage or gastrointestinal bleeding; who have congestive heart failure pulmonary or leg edema, or complicated by pregnancy; dermatitis, gangerine, or newly recieved transplantation of the legs, severe atherosclerosis or other ischemic diseases of the legs;who have severe deformation of the legs.

Design outcomes

Primary

MeasureTime frame
color doplar ultrasound of the lower extremity vein;

Secondary

MeasureTime frame
hematoglobin;white blood cell count;hct;plt;PT;APTT;Fbg;TT;D-Dimer;AT-?;t-PA;PAI;? factor;? factor;Protein c;Protein s;

Countries

China

Contacts

Public ContactZhenyu Zhang
zhangzhenyu@coga.org.cn+86 13801237287

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026